We are using the model of the developing mouse embryo to elucidate the pattern of arginase expression in mammalian cells in normal animals and in arginase I (AI) deficiency during development by digoxigenin-labeled RNA in situ hybridization. Our goal is to understand the regulation of these isozymes, with the expectation that this knowledge will help patients suffering from AI deficiency. We found that AI mRNA was widely and strongly expressed in the normal developing mouse embryo; in contrast, a relatively strong AII mRNA signal was found only in the intestine. In the AI knockout mouse embryo, no AII overexpression was found. These results indicated that arginases are needed in mouse embryonic development and AI is the principal form required. The strong AI expression in the peripheral nervous system suggests that the pathogenesis of the neurological retardation in AI deficiency may be conditioned by AI deficiency in the nervous system during embryonic development. q 2002 Elsevier Science Ireland Ltd. All rights reserved.
Results and discussion
Two forms of arginase, AI and AII, exist in mammals, both catalyzing the hydrolysis of arginine to ornithine and urea. AI functions primarily to detoxify ammonia as part of the urea cycle and is absent in the arginase deficient patient (Brusilow and Horwich, 2001 ), whereas AII is thought to be more important in biosynthesis of ornithine and may be significantly induced in arginase deficient patient (Grody et al., 1989 (Grody et al., , 1993 . Aside from the urea cycle, the role of arginase in development and the need to evolve a second, similar isozyme is unknown. Arginase could be important in providing ornithine as a precursor to the synthesis of polyamines, which play a pivotal role in the control of DNA, RNA and protein synthesis during cell growth, differentiation and development (Fozaed et al., 1980; Pegg et al., 1982; Hougaard, 1992) and are important in embryonic development (Kusunoki and Yasumasu, 1978; Heby and Emanuelsson, 1981; MacRae et al., 1998) . We report here that arginase is expressed in embryonic development.
AI was expressed strongly and widely in many tissues predominantly in the peripheral nervous system, the digestive system and also in leukocytes . Relatively strong AII expression was found only in the intestine (Figs. 1 and 6A). Cells were negative for AI and AII sense probes in all sections. AI mRNA signal was not found in any tissues or cells in the AI knockout mouse at embryonic day (E) 17 and postnatal day (P) 1 (e.g. Figs. 2E,H and 4F,N).
AI expression in the nervous system
AI was expressed in the peripheral nervous system in the ganglion cells in all E13-P1 samples. AI expression was found to be particularly strongly in the dorsal root ganglia of the spinal nerves (Fig. 2F ,G,G1,J,J2,K), in the ganglia of the cranial nerves (e.g. Figs. 2K,K2 and 5C), and in the ganglion cell layer of the retina ( Fig. 2A-D) . In the central nervous system, weak AI expression could be seen in the spinal cord (Fig. 2J1) and parts of the brain (Fig. 2K,K1 ). These results indicated that AI is needed in neurons in embryonic development, and is functional in the afferent neurons more than efferent neurons.
AI expression in the leukocytes
AI was expressed in the leukocytes that were present in the tissues (Fig. 3 (K1) is an enlargement of the boxed area of (K); weak AI expression in the medulla oblongata could be seen. Br, brain; CL, central line of spinal cord; Co, cochlea; E, epithelium; GL, ganglion cell layer of retina; L, lens; MO, medulla oblongata; P, pigment epithelium of retina; R, retina; S, spinal cord; X, ganglion of vagus nerve. Scale bars: A-C,E 150 mm; D,F-J, 300 mm; J1,K1, 100 mm; K, 400 mm; G1,G2, 40 mm; J2,K2, 20 mm.
and large blood vessels. AI-positive macrophages/monocytes appeared in the alveolar cavity or alveolar wall at P1 (Fig. 3E-G) when the lung is beginning to function by itself. AI can be induced in macrophages or monocytes in culture (Sonoki et al., 1997; Munder et al., 1999) and also in humans by surgery or injury Tsuei et al., 2001 ). The present study showed that AI could be induced in the leukocytes in changed physiological conditions.
AI expression in the digestive system and in the other tissues
In the digestive system, AI was expressed in the liver, pancreas, salivary glands and surface epithelium of the esophagus, stomach and small intestine (Fig. 4 and Table  1 ). AI was also found in many other tissues such as lymph nodes, thymus and kidney ( Fig. 5 and Table 1) .
The results presented here demonstrated that AI is needed for many tissues that do not have, and will not have, a urea cycle. AI is concerned with cell differentiation and maturation beyond just the urea cycle, during the period of embryonic development.
AII expression in the mouse embryo
The expression of AII mRNA was much weaker than that of AI in all embryos and neonates, and the relatively strong AII expression was seen only in the intestine (Figs. 1I 00 and 6A). AII expression was not found in the nervous system either in the normal animals (Fig. 2I) or AI knockout animals. We also could not find AII overexpression in the AI knockout animals (Fig. 6B,D) , indicating that AII is not induced in AI deficiency in the embryonic stage.
Experimental procedures

Animal and tissue preparation
Two groups of C57BL6 mouse embryos were used for this study. One group consisted of normal animals which were killed at E (embryonic day) 13, 15 and 17 and P (postnatal day) 1. Another group consisted of AI knockout mice Fig. 3 . AI mRNA expression in the leukocytes. In the intestine, concentrated AI-positive cells were seen in the submucosa at E17 (A), and this expression was decreased at P1 (B1); H&E staining showed that the concentrated AI-positive cells were lymphocytes (B2, the lymphocytes are outlined). (C1-D2) Leukocytes in the pericardial cavity in the auricle area at P1, the fibrous pericardium in auricle is outlined (C1, D1). (D1) is H&E staining from a contiguous section of (C1), (C2) and (D2) are enlargements from the areas marked by black arrow in (C1) and (D1), respectively. In the pericardial cavity infiltrated leukocytes including granular leukocytes, lymphocytes and macrophages could be seen (D1, D2), and strong AI expression was present in those infiltrative leukocytes (C1, C2). In the lung, scattered AI-positive macrophages/monocytes were seen in the alveolar wall (white arrows in E-G) and in the alveolar cavity (black arrows in E-G) at P1. (F) Two monocytes (indicated by arrowheads) moving out from a capillary into the alveolar wall, and a macrophage (indicated by black arrow) moving out from alveolar wall into alveolar cavity. (G) A macrophage in the alveolar cavity. C, alveolar cavity; Ca, capillary; M, Mucosa; Ms, muscularis; RC, red cell; S, serosa; SM. Submucosa; W, alveolar wall. Scale bars: A, B1,B2,E, 100 mm; C1,D1, 300 mm; C2,D2, 20 mm; F,G, 30 mm. Fig. 4 . AI mRNA expression in the digestive system in the developing mouse embryo. AI expression was increased from E13 (A), E15 (B), E17 (C) to P1 (D) in the liver whereas the expression was decreased in the pancreas from E13 to P1. In the surface epithelium of stomach, weak expression was seen in E13 (A), but much stronger expression was found in E15 (B) and E17 (C,H). Only very weak expression could be seen at P1 (D). (E) E17 with AII antisense; AII mRNA was seen in the intestine but was not seen in the other tissues. (F) E17 AI knockout mouse with AI antisense; no AI signal was seen. (G) and (H) are enlargements of liver and stomach from (C); AI mRNA was present in the cytoplasm of hepatocytes (G) and in the cytoplasm (indicated by black arrow) of the surface epithelial cells in the stomach (H, the nucleus is indicated by the white arrow). (I) AI expression was seen in the glandular cells of pancreas at E13. But at P1, AI signal was only seen in the islet of Langerhans (J, see black arrows). In the parotid gland, AI expression was only seen at P1 (K). (L-N) Submaxillary gland. Strong AI expression was seen at E17 (L) and P1 (M). (N) AI knockout E17 with AI antisense; no expression was seen. C, cytoplasm; In, intestine; K, kidney; L, liver; N, nucleus; Oe, esophagus; P, pancreas; S, stomach. Scale bars: A,K-N, 200 mm; B-F, 350 mm; G-J, 40 mm. (Iyer et al., in press) at E17 and P1. The tissue preparation was performed as described previously (Yu et al., 2001 ).
Synthesis of DIG RNA probes and in situ hybridization
The AI and AII cDNAs fragment were 956 bp (bases 236-1192; Chieko, 1996) and 909 bp (bases 131-1040; Gotoh et al., 1996; Iyer et al., 1998) , respectively. RNA probes were synthesized and labeled with DIG RNA labeling mixture (Boehringer Mannheim, Indianapolis, IN) according to the procedure described previously (Yu et al., 2001) . RNA in situ hybridization was done following the protocol from Boehringer Mannheim. Brown signal was judged as positive, and positive was judged to have strong (see e.g. Fig.2J,J2 ), moderate (see e.g. Fig. 2G,G1 ) or weak levels (see e.g. Fig. 2J1,K1 ) by the intensity of brown signal.
Histological staining
Origin of the tissues or cells was judged by morphological study. Histological staining was performed with Meyer's hematoxylin and eosin (H&E staining). Fig. 5 . AI mRNA expression in the other tissues. AI was expressed in many other tissues. Strong AI expression in the lamina propria in the nasal cavity was seen at E13 (A) and E15 (B). The surface epithelium in the nasopharynx and oropharynx (C, from P1), and in the lumen of urogenital sinus (D, from E17) exhibited the expression. (E1) AI expression in a cervical lymph node at P1. (F1) AI expression in the thymus at P1, the expression was found in the medulla (indicated by arrows) but not in the cortex. (E2) and (F2) were stained by H&E from a contiguous section from the same area of (E1) and (F1), respectively. (G) AI expression in the glomeruli in the kidney at E13, glomeruli are indicated by arrows. Car, cartilage; Co, neopallial cortex; E, epithelium; LP, lamina propria; Ly, lymph node; NP, nasopharynx; OP, oropharynx; P, pigment epithelium of retina; R, rectum; Su, submaxillary gland; Ur, lumen of urogenital sinus; V, trigeminal ganglion. Scale bars: A,E1,E2,F1,F2,G, 200 mm; B, 100 mm; C, 400 mm; D, 300 mm. 
